UNSPSC 51384502: Bakeprofen

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C16H14O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier VMS3A207FA, chemically known as propionic acid, 2-(m-benzoylphenoxy)- but generally known as bakeprofen, which bears US NIH Compound Identifier 179346. European Medicines Agency schedules Bakeprofen in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06089MIG.

UNSPSC 51384502 Bakeprofen is a Commodity code that covers pharmaceutical products procured by state and local health agencies, though recent state and local solicitations under this code show minimal activity aligned with the bakeprofen product name itself. Instead, the recent opportunities tag unrelated pharmaceutical and drug-management purchases — naloxone and drug deactivation systems, generic multi-source pharmaceuticals and OTC products, and direct-to-manufacturer prescription programs — suggesting that the code may be misapplied to these solicitations or that the code's nominal scope does not reflect current procurement patterns. State and local buyers using pharmaceutical commodity codes include county health departments (Seminole County, Florida), state health and human services commissions (Texas HHS Commission), and multistate cooperative purchasing alliances (MMCAP, administered by the Minnesota Department of Administration's Office of State Procurement). The issuing bodies vary in scale and approach, from single-county health purchases to multi-state cooperative frameworks serving state and local facilities across multiple jurisdictions.

Geographic activity in recent solicitations centers on Florida, Texas, and Minnesota, with MMCAP's cooperative purchasing also extending to Oregon. Representative recent opportunities include Seminole County's IFB 60459723LAS (posted June 30, 2026; due July 26, 2023) seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries, MMCAP's RFP S1070000015802 (posted January 20, 2026; proposals due March 26, 2026) establishing multiple contracts for generic pharmaceuticals and OTC products through authorized wholesalers with awards effective July 1, 2026, and the Texas HHS Commission's RFI HHS0017013 (posted April 3, 2026) gathering vendor capabilities for a direct-to-manufacturer prescription program. The code shows little recent relevant activity directly aligned with bakeprofen procurement; prospective bidders should verify actual category alignment before pursuing opportunities tagged under this code.